Celera Genomics Group completed a mjor step toward deciphering the entire human genetic blueprint, adding fuel to a rally in genomics stocks. The biotechnology company said it sequenced 99 percent of all the human genetic material in seven months. It will now use supercomputers to figure out how the DNA fragments it and fits together to form the human genome, the collection of three billion chemical letters that form the human DNA at the center of every cell.